EFFICACY AND SAFETY OF ABALOPARATIDE IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRAGILITY FRACTURE

被引：0
|
作者：
Harvey, N. C. [1 ]
机构：
[1] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Ctr, Southampton SO16 6YD, Hants, England
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
SY9
引用
收藏
页码：S581 / S581
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study
    Lewiecki, E. Michael
    Czerwinski, Edward
    Recknor, Chris
    Strzelecka, Anna
    Valenzuela, Guillermo
    Lawrence, Mary
    Silverman, Stuart
    Cardona, Jose
    Nattrass, Susan M.
    Binkley, Neil
    Annett, Miriam
    Pearman, Leny
    Mitlak, Bruce
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 (10) : 1404 - 1414
  • [2] Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis
    Miller, Paul D.
    Bilezikian, John P.
    Fitzpatrick, Lorraine A.
    Mitlak, Bruce
    McCloskey, Eugene, V
    Cosman, Felicia
    Bone, Henry G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (11) : 1861 - 1872
  • [3] Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis
    Leder, Benjamin Z.
    Mitlak, Bruce
    Hu, Ming-Yi
    Hattersley, Gary
    Bockman, Richard S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 938 - 943
  • [4] Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture
    Saag, Kenneth G.
    Williams, Setareh A.
    Wang, Yamei
    Weiss, Richard J.
    Cauley, Jane A.
    CLINICAL THERAPEUTICS, 2020, 42 (06) : 1099 - +
  • [5] Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture
    Clarke, Bart
    Kostenuik, Paul
    Wang, Yamei
    Tough-DeSapri, Kristi
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1448 - 1448
  • [6] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    N.B. Watts
    G. Hattersley
    L.A. Fitzpatrick
    Y. Wang
    G.C. Williams
    P.D. Miller
    F. Cosman
    Osteoporosis International, 2019, 30 : 1187 - 1194
  • [7] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1187 - 1194
  • [8] Functional hypoparathyroidism in postmenopausal women with fragility fracture
    Amouzougan, Adamah
    Chopin, Florence
    Laporte, Silvy
    Vico, Laurence
    Thomas, Thierry
    JOINT BONE SPINE, 2012, 79 (02) : 170 - 175
  • [9] Correction to: Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
    Michael R. McClung
    Gregory C. Williams
    Gary Hattersley
    Lorraine A. Fitzpatrick
    Yamei Wang
    Paul D. Miller
    Calcified Tissue International, 2018, 102 : 634 - 634
  • [10] Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk
    McClung, Michael R.
    Betah, Donald
    Deignan, Cynthia
    Shi, Yifei
    Timoshanko, Jen
    Cosman, Felicia
    ENDOCRINE PRACTICE, 2023, 29 (09) : 716 - 722
12345